{"edition":"los-angeles","organization":"Radiant Health Centers","organizationId":"org:radiant-health-centers","boundaryVersion":"OMB-23-01-2023-07-21","updated":"2026-10-08","display":{"metric":{"id":"daly-equivalent","years":1,"label":"DALY","priceLabel":"$ / DALY"},"priceUSD":17598363.38618442,"canonicalPriceUSDPerTenEquivalentYears":175983633.8618442,"conversion":"display only; QALYs and income equivalents are not measured clinical DALYs"},"listDisplay":{"metric":{"id":"daly-equivalent","years":1,"label":"DALY","priceLabel":"$ / DALY"},"priceUSD":17598363.38618442,"canonicalPriceUSDPerTenEquivalentYears":175983633.8618442,"conversion":"display only; QALYs and income equivalents are not measured clinical DALYs"},"model":{"version":"la-radiant-clinical-components-v1","costScope":"Full recipient gross expense, not selected clinical-program budget; unrecognized volunteer and outside care resources unknown.","geographicAttribution":"g=.98 judgment for Orange County-centered resident outcomes. No measured LA/Orange address fraction; sensitivity .9–1.","formula":"C=13585902+240092=13825994. A(T)=sum(y=1..T)(1.03^-y). QA=N*s*h*f*a*b*r*ta*qe/1.03; QP=N*s*p*f*a*b*i*ep*v*A(T)/1.03; QM=M*s*em*tm*b*qm/1.03. QLA=(QA+QP+QM)*z*g. Central QA=.1703883495, QP=.1635041709, QM=.5568567961 before overlap/geography; QLA=.7856408972. Price10=10*C/QLA. Qportfolio=QLA+Qother-H.","counterfactual":"Other clinics, insurance, Ryan White services, 340B financing and usual counseling continue. a limits ART/PrEP exposure to meaningful changes from alternatives. b applies separately to the ordinary gift's resource response. Mental transfer tm includes both modality/intensity and alternative counseling.","attribution":"ART and PrEP shares are mutually exclusive in one modeled year, with h+p<=1. Annual counts are not prescription-years. SMART r is a randomized-strategy follow-up-year rate, not a biological effect per extra medication year. Counseling effect is additional to usual care; z further reduces potential cross-branch overlap. No test, contact, housing count or secondary infection is credited again.","uncertainty":"Explicit conditional clinical estimate, not whole-portfolio return. Treatment shares and marginal responsiveness are subjective; broad scenarios, zero and harm are retained. Public fiscal-year counts lag current costs.","nativeOutcomes":"At s=1, the 1,872 clinic patients imply 748.8 assumed ART patients and 280.8 PrEP patients. Three-quarter-year exposure, .25 incremental strategy fraction and .25 funding response yield 35.1 ART strategy-follow-up years and 13.1625 additional PrEP person-years. The latter avert .1131975 infections at i=.01 and effectiveness .86. Counseling uses 322*.5*.25*.25=10.0625 transferred, donor-responsive CoBalT-equivalent offers. These fractional outputs are model expectations, not observed people.","inputs":[{"name":"C","value":13825994,"unit":"USD annual gross recipient expense","basis":"observed","rationale":"Audit total plus original-return event costs; drugs and recognized donated materials retained.","sourceIds":["audit25","99025","d25"]},{"name":"N","value":1872,"unit":"FY2024 clinic patients","basis":"observed","rationale":"Not diagnosis-specific or treatment person-years.","sourceIds":["impact"]},{"name":"M","value":322,"unit":"FY2024 unique counseling clients","basis":"observed","rationale":"Not completed courses or responders.","sourceIds":["impact"]},{"name":"s","value":1,"unit":"current capacity relative to FY2024 counts","basis":"judgment","rationale":"No FY2025 unique counts; test .5–1.5 without assuming cost growth proves volume growth.","sourceIds":["impact","99025"]},{"name":"h","value":0.4,"unit":"clinic share receiving modeled ART continuity support","basis":"judgment","rationale":"Actual medication mix unavailable; test .2–.6.","sourceIds":["art","audit25"]},{"name":"p","value":0.15,"unit":"clinic share receiving modeled PrEP","basis":"judgment","rationale":"Actual medication mix unavailable; test .05–.3; h+p never exceeds one.","sourceIds":["prep"]},{"name":"f","value":0.75,"unit":"strategy or PrEP follow-up years per annual patient","basis":"judgment","rationale":"Exposure and retention unavailable; cap at one year, test .25–1.","sourceIds":["impact"]},{"name":"a","value":0.25,"unit":"medication-strategy exposure additional to alternatives","basis":"judgment","rationale":"Meaningful interruption or absence of PrEP, not simply a few days faster; test .05–.6.","sourceIds":["art","billing"]},{"name":"b","value":0.25,"unit":"proportional marginal funding response","basis":"judgment","rationale":"Payer, collections and donor substitution; test .05–.75.","sourceIds":["audit25","billing"]},{"name":"r","value":0.02,"unit":"composite events per randomized ART-strategy follow-up year","basis":"observed","rationale":"SMART 3.3 minus 1.3 per100; not effect per extra ART year.","sourceIds":["smart"]},{"name":"ta","value":0.5,"unit":"ART strategy-effect transfer","basis":"judgment","rationale":"Modern care gaps differ from protocol interruption; test .1–1.","sourceIds":["smart"]},{"name":"qe","value":0.5,"unit":"finite one-year QALY area per composite event prevented","basis":"judgment","rationale":"Event mix unobserved; no remaining-lifetime multiplier; test .1–1.","sourceIds":["smart"]},{"name":"i","value":0.01,"unit":"annual HIV incidence absent PrEP in modeled group","basis":"judgment","rationale":"Not local measured risk; test .002–.03.","sourceIds":["proud"]},{"name":"ep","value":0.86,"unit":"PrEP relative incidence reduction","basis":"observed","rationale":"PROUD trial estimate, conditional on transferable delivery.","sourceIds":["proud"]},{"name":"v","value":0.1,"unit":"annual survival-adjusted utility difference after infection prevented","basis":"judgment","rationale":"Finite health-area assumption, includes survival once; test .03–.15.","sourceIds":[]},{"name":"T","value":20,"unit":"years after infection prevented","basis":"judgment","rationale":"No health area after year20; low scenario10.","sourceIds":[]},{"name":"em","value":0.5,"unit":"counseling share clinically compatible with depression benefit","basis":"judgment","rationale":"Not measured treatment-resistant depression; test .1–.7.","sourceIds":["mental","cobalt"]},{"name":"tm","value":0.25,"unit":"counseling effect transfer including alternatives","basis":"judgment","rationale":"Current mainly-group format is not CoBalT individual CBT; test .1–1.","sourceIds":["mental","cobalt"]},{"name":"qm","value":0.057,"unit":"QALY per randomized CoBalT offer over one year","basis":"observed","rationale":"External package versus usual care; not Radiant's observed effect.","sourceIds":["cobalt"]},{"name":"z","value":0.9,"unit":"cross-component non-overlap factor","basis":"judgment","rationale":"No extra housing/nutrition benefit added; residual shared health areas discounted; test .7–1.","sourceIds":[]},{"name":"g","value":0.98,"unit":"LA/Orange resident benefit share","basis":"judgment","rationale":"Orange County-focused services; exact residence unknown.","sourceIds":["current"]},{"name":"d","value":0.03,"unit":"annual discount","basis":"judgment","rationale":"Infection health area discounted by year and one initial event year; others one year.","sourceIds":[]},{"name":"Qother","value":null,"unit":"non-overlapping remaining portfolio health","basis":"unknown","rationale":"Primary/reproductive care, housing, food and other effects unpriced.","sourceIds":["current","audit25"]}],"scenarios":[{"id":"central","label":"Conditional selected clinical health","costUSD":13825994,"allPopulationQalys":0.8016743848994923,"editionQalys":0.7856408972015024,"assumptions":"s=1;h=0.4;p=0.15;f=0.75;a=0.25;b=0.25;ART transfer=0.5;Q/event=0.5;T=20;v=0.1;mental eligibility=0.5;mental transfer=0.25;z=0.9;g=0.98;incidence=0.01. Joint subjective stress test, not confidence bounds."},{"id":"low","label":"Weak delivery and transfer","costUSD":13825994,"allPopulationQalys":0.0031430507229117306,"editionQalys":0.0028287456506205576,"assumptions":"s=0.5;h=0.2;p=0.05;f=0.25;a=0.05;b=0.05;ART transfer=0.1;Q/event=0.1;T=10;v=0.03;mental eligibility=0.1;mental transfer=0.1;z=0.7;g=0.9;incidence=0.002. Joint subjective stress test, not confidence bounds."},{"id":"high","label":"Favorable delivery and transfer","costUSD":13825994,"allPopulationQalys":49.94448521193465,"editionQalys":49.94448521193465,"assumptions":"s=1.5;h=0.6;p=0.3;f=1;a=0.6;b=0.75;ART transfer=1;Q/event=1;T=20;v=0.15;mental eligibility=0.7;mental transfer=1;z=1;g=1;incidence=0.03. Joint subjective stress test, not confidence bounds."},{"id":"zero","label":"No additional clinical health","costUSD":13825994,"allPopulationQalys":0,"editionQalys":0,"assumptions":"b=0 or relevant causal effects are zero."},{"id":"adverse","label":"Illustrative net harm","costUSD":13825994,"allPopulationQalys":-1,"editionQalys":-1,"assumptions":"One LA QALY net loss from adverse effects, disruption or displaced care; not observed."},{"id":"portfolio-unknown","label":"Whole-portfolio return unestimated","costUSD":13825994,"allPopulationQalys":null,"editionQalys":null,"assumptions":"Other pathways cannot be assumed zero for ranking."},{"id":"income-unknown","label":"Combined household resources unknown; clinical reference retained","costUSD":13825994,"allPopulationQalys":0.8016743848994923,"editionQalys":0.7856408972015024,"incomeUnknown":true,"assumptions":"Unknown resources are not zero; all six original clinical worlds unchanged."}],"sensitivity":["Central $175,983,633.86 per10 LA QALYs; favorable $2,768,272.40; weak $48,876,766,269.06.","No counseling transfer removes the largest central branch; this is a material assumption, not a robust HIV-only price.","The scenario stops ART-event and counseling benefits after one year and post-infection utility after20; ongoing future treatment cost is not borrowed to claim longer intervention exposure.","Halving b doubles the positive price; improvement in billing could either expand care or substitute for philanthropy.","Adding unrecognized volunteer and outside treatment resources increases social cost; recognized drugs and event goods are already retained.","FY2024 count versus FY2025 expense mismatch is explicit, tested through s, not hidden in a synthetic mean."],"missingInputs":["Current unique ART/PrEP patients, duration, adherence, viral suppression and counterfactual care gaps.","Local PrEP risk and persistence.","Counseling diagnoses, modality, completion and comparative utilities.","Unrestricted marginal allocation and payer/collection substitution.","Client-address geography and deduplication across clinical/social services.","Unrecognized volunteer resources and non-overlapping remaining health pathways."],"incomeAssessment":{"status":"assessed-unknown","scope":"Targeted LA/Orange joint private care payments, food/housing/transport assistance and participant/caregiver resource costs; partial clinical reference retained.","sourceIds":["billing","ra-nutrition26","ra-social26","ra-transport26"],"acceptance":"independently-reviewed","evidence":"docs/geography-discovery/la-radiant-alpha-income-20261008/root-acceptance.md","rationale":"Current fee and assistance pathways are real, but retained amounts, actual alternative private payments and matching unique household incidence are unidentified. Clinic counts and pharmacy revenue do not supply this financial cohort.","directions":["Fees and full access/time/caregiver burdens may reduce resources even when clinical response is zero; supported transport and displaced purchases may improve them.","Joint household gains need net taxes/benefit withdrawals, finite delivery and additionality against existing insurance, Ryan White and other providers.","Positive overlap limits gains only; full negative costs remain, and public payer financing and real-resource costs are separate.","Broader work effects and the ordinary-gift full portfolio remain unquantified, not zero; no survivor earnings or retail drug value added."]}},"sources":[{"id":"audit25","title":"FY2025 original audited statements; auditor date January 31, 2026","url":"https://projects.propublica.org/nonprofits/display_audit/2025-02-GSAFAC-0000401968","publisher":"Radiant / Stephens, Reidinger & Beller LLP","published":null,"retrieved":"2026-09-14"},{"id":"audit24","title":"FY2024 original audited statements","url":"https://projects.propublica.org/nonprofits/display_audit/2024-02-GSAFAC-0000359618","publisher":"Radiant / independent auditor","published":null,"retrieved":"2026-09-14"},{"id":"audit23","title":"FY2023 original audited statements and direct event costs","url":"https://projects.propublica.org/nonprofits/display_audit/2023-02-GSAFAC-0000402587","publisher":"Radiant / independent auditor","published":null,"retrieved":"2026-09-14"},{"id":"99025","title":"FY2025 original return and netted event cost","url":"https://projects.propublica.org/nonprofits/full_text/202630849349300343/IRS990","publisher":"Radiant / IRS","published":"2026-03-25","retrieved":"2026-09-14"},{"id":"99024","title":"FY2024 original return and netted event cost","url":"https://projects.propublica.org/nonprofits/full_text/202500159349302735/IRS990","publisher":"Radiant / IRS","published":"2025-01-15","retrieved":"2026-09-14"},{"id":"d25","title":"FY2025 audit-to-return expense reconciliation","url":"https://projects.propublica.org/nonprofits/full_text/202630849349300343/IRS990ScheduleD","publisher":"Radiant / IRS","published":"2026-03-25","retrieved":"2026-09-14"},{"id":"d24","title":"FY2024 audit-to-return expense reconciliation","url":"https://projects.propublica.org/nonprofits/full_text/202500159349302735/IRS990ScheduleD","publisher":"Radiant / IRS","published":"2025-01-15","retrieved":"2026-09-14"},{"id":"impact","title":"FY2024 annual report: clinical counts; financial table not used as authority","url":"https://www.radianthealthcenters.org/wp-content/uploads/2025/02/Radiant-Health-Centers-Annual-Report-2023-2024.pdf","publisher":"Radiant","published":null,"retrieved":"2026-09-14"},{"id":"current","title":"Current integrated Orange County services","url":"https://www.radianthealthcenters.org/","publisher":"Radiant","published":null,"retrieved":"2026-09-14"},{"id":"art","title":"Current Rapid ART delivery","url":"https://www.radianthealthcenters.org/lgbtq-medical-clinic/rapid-art-hiv-treatment","publisher":"Radiant","published":null,"retrieved":"2026-09-14"},{"id":"prep","title":"Current PrEP services","url":"https://www.radianthealthcenters.org/lgbtq-medical-clinic/prep","publisher":"Radiant","published":null,"retrieved":"2026-09-14"},{"id":"mental","title":"Current counseling format and scope","url":"https://www.radianthealthcenters.org/lgbtq-counseling","publisher":"Radiant","published":null,"retrieved":"2026-09-14"},{"id":"billing","title":"Insurance, FQHC status and sliding fees","url":"https://www.radianthealthcenters.org/lgbtq-medical-clinic/payment-billing","publisher":"Radiant","published":null,"retrieved":"2026-10-08"},{"id":"donate","title":"Ordinary recipient giving page","url":"https://www.radianthealthcenters.org/get-involved/donate","publisher":"Radiant","published":null,"retrieved":"2026-09-14"},{"id":"smart","title":"SMART randomized continuous versus interrupted ART strategies","url":"https://doi.org/10.1056/NEJMoa062360","publisher":"SMART Study Group / NEJM","published":null,"retrieved":"2026-09-14"},{"id":"proud","title":"PROUD randomized PrEP trial","url":"https://pubmed.ncbi.nlm.nih.gov/26364263/","publisher":"McCormack and colleagues / Lancet","published":"2015-09-09","retrieved":"2026-09-14"},{"id":"cobalt","title":"CoBalT randomized clinical and economic evaluation","url":"https://pubmed.ncbi.nlm.nih.gov/24824481/","publisher":"Wiles and colleagues / NIHR","published":null,"retrieved":"2026-09-14"},{"id":"ra-nutrition26","title":"Nutrition assistance","publisher":"Radiant Health Centers","url":"https://www.radianthealthcenters.org/social-services/nutrition-services","published":null,"retrieved":"2026-10-08"},{"id":"ra-social26","title":"Financial assistance and housing resources","publisher":"Radiant Health Centers","url":"https://www.radianthealthcenters.org/social-services","published":null,"retrieved":"2026-10-08"},{"id":"ra-transport26","title":"Qualified transport assistance","publisher":"Radiant Health Centers","url":"https://www.radianthealthcenters.org/transportation","published":null,"retrieved":"2026-10-08"}]}